However, leucine-rich alpha-2-glycoprotein is known to be involved in a wide spectrum of pathological conditions, including different types of cancer (discussed in [36]), which raises the question concerning the specificity of this protein as a marker for PDAC diagnosis. Here, LRG1 is linked to cancer.